Daniel S. Chan
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
Journal: JACC. Cardiovascular imaging
Published: April 14, 2021
Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: August 18, 2020
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes.
Journal: Therapeutic advances in endocrinology and metabolism
Published: February 14, 2019
Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: August 25, 2018
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.
Journal: European journal of heart failure
Published: August 07, 2018
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure.
Journal: Clinical proteomics
Published: April 20, 2018
Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.
Journal: European journal of heart failure
Published: August 06, 2017
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
Journal: Journal of the American College of Cardiology
Published: September 07, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026